ABSTRACT. yCarboxylation of vitamin K-dependent clotting factors may be a key regulatory element in output of these proteins from liver to blood in the developing neonate. We have investigated the effect of hormones and growth factor on the vitamin K-dependent carboxylation system in neonatal rats and cultured fetal hepatocytes. Of the hormones and growth factor tested, only dexamethasone had a significant effect on the system. When dexamethasone was administered to newborn rats, there was a delayed response that produced significant enhancement of carboxylase activity 6 d after injection of the drug. A similar delayed response to the drug could also be demonstrated in cultured fetal hepatocytes. When cultured in the presence of 0.1-1 pM dexamethasone, cellular carboxylase activity was little affected by the drug the first 2 d of culture but the activity was increased more than threefold by 4 d in culture. Microsomal membranes from neonatal rat livers and fetal hepatocytes treated with dexamethasone showed enhanced vitamin K-dependent 14C labeling of the factor X membrane precursor pool. Enhanced labeling of the factor X membrane precursor pool has also been demonstrated in rats and HepG2 cells treated with warfarin. The data suggest that 1 ) y-carboxylation of clotting factors is regulated by glucocorticoids in the developing liver, and 2) dexamethasone stimulates intracellular y-carboxylation of the factor X precursor by a mechanism that currently is unknown. (Pediatr Res 30: 281-285,1991) Abbreviations TAT, tyrosine aminotransaminase Vitamin K1H2, the fully reduced hydroquinone form of vitamin K1 CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid Ts, triiodothyronine Vitamin K deficiency has traditionally been associated with bleeding complications in the newborn (1). Recent reports (2-5) have documented, however, that fetal and neonatal livers are not normally deficient in vitamin K because PIVKA (Protein Induced in Vitamin K Absence) factors cannot be detected in most fetal and newborn blood plasmas. Bleeding problems in newborns with sufficient liver vitamin K stores are more unclear. These problems are seen most and are usually more severe in
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To get insight into the etiology of neonatal bleeding problems it is necessary to understand the processes involved in maturation of the hemostatic system. This includes an understanding of the vitamin K-dependent carboxylation system in the developing liver that is responsible for postribosomal y-carboxylation of clotting factors, 11, VII, IX, X, protein S, and protein C (7, 8). yCarboxylation of these clotting factors results in their Ca2+ binding properties which are essential for normal hemostasis (9). The vitamin K-dependent carboxylation system consists of the vitamin K-dependent carboxylase, an integral membrane protein of the endoplasmatic reticulum (lo), and enzymes involved in reduction of vitamin K to its active cofactor form, vitamin K hydroquinone (1 I). In a previous report, we provided evidence for an ongoing maturation process of the vitamin K-dependent carboxylation system in fetal and neonatal rats (7). In this report, we have focused on regulation of vitamin K-dependent carboxylation by hormones and growth factors. Data are presented that demonstrate that dexamethasone stimulates vitamin K-dependent carboxylation in neonatal livers and fetal hepatocytes in culture. Dexamethasone is also shown to enhance intracellular y-carboxylation of the factor X precursor.
MATERIALS AND METHODS

Treatment of Neonatal Rats with Hormones. Pregnant
Sprague-Dawley rats (12 d pregnant) were purchased from Zivic Miller Laboratories (Zalinople, PA) and brought to our animal facilities where they gave birth to their offspring. On d 1 after birth (24 h after delivery), the rat litters were divided into three groups with eight litters in each group. Each neonatal rat in group A received 10 pg of dexamethasone per gram body wt as an intraperitoneal injection in saline. Each neonatal rat in group B received 40 m u of insulin as an intraperitoneal injection in saline. Group C was the control group, and each neonatal rat in this group was given an equivalent amount of saline. The neonatal rats stayed with the mothers until they were killed on d 2, 3, 5, and 7 after birth (two litters were killed on each day). The livers were removed from the neonatal rats. The pooled livers from two litters were washed in ice-cool saline and were used for preparation of liver microsomes as described below.
Preparation and Culture ofFetal Hepatocytes. Pups from 18-d pregnant rats were aseptically removed from the uterus and killed by cervical dislocation. The pup livers were surgically removed, placed in Dulbecco's Ca2+-and Mg2+-free PBS (PBS "A"), and finely minced with a scalpel. Approximately 3 g of minced liver tissue was placed into a 250-mL conical flask containing 20 mL of PBS "A" and allowed to shake at 37°C for 10 min. The supernatant was discarded, and the wash was repeated. The tissue was then washed two times with PBS "A" SDS-PAGE and Fluorography of I4C-labeled Carboxylase Subcontaining 0.5 mM EGTA. Hepatocytes were prepared by diges-strates. Endogenous carboxylase protein substrates in microsotion with 20 mL of Hanks' Mg2+-free balanced salt solution ma1 membrane fragments were I4C-labeled in vitro as described containing 5 mM CaC12, 0.05% collagenase, and 0.1 % hyaluron-(12) and subjected to SDS-PAGE in 10% gels for fluorography idase (wt/vol) at 37°C for 60 min. The remaining cloudy suspen-(12). sion was filtered through 150-pm-pore-size cloth to remove cell Materials. Vitamin KI, warfarin, dexamethasone, insulin, epclumps and undigested material. The filtrate was centrifuged idermal growth factor, and platelet-derived growth factor were (200 x g for 2 min), and the cell pellet was washed once with purchased from Sigma Chemical Co. (St. Louis, MO). IL-1 was FCS and washed twice with cell culture medium (arginine-free a gift from Dr. Charles McCall, The Bowman Gray School of Eagle minimal essential medium supplemented with 0.6 mM L-Medicine, (Winston-Salem, NC). Vitamin K, was reduced to ornithine, 10% FCS, 1% [vol/vol] of Gibco's antibiotic-antimy-vitamin KIH2 as described by Sadowski et al. (14) . The pentacotic mixture, and 1 % kanamycin sulfate). In some experiments, peptide carboxylase substrate FLEEL was purchased from Vega the FCS was charcoal treated before use. The cells were plated Fox Biochemicals Division (Tucson, AZ). NaHi4C03 (60 mCi/ in 100-mm tissue culture dishes at a density of 2 x lo5 cells/ mmol) was from Amersham Corp. (Arlington Heights, IL). Procm2. The dishes were incubated in an atmosphere of air (95%) tein was measured by using the Bio-Rad protein assay. Antisera and C 0 2 (5%). After 24 h, the medium was changed to remove against rat prothrombin and rat factor X were obtained as cellular debris and contaminating erythrocytes.
described (12). Statistical analysis was done by applying a t test. Treatment of Fetal Hepatocytes. After the first 24 h in culture, cultured fetal hepatocytes were treated with dexamethasone (0.1 and 1 pM) and insulin (10 nM) for 5 d (d 1-5). Cells were RESULTS harvested on d 2, 3, 4, and 5. The medium was replaced daily Fetal hepatocytes. The preparation of fetal hepatocytes, when with fresh medium containing hormone. In a parallel set of cultured for 24 h in an arginine-free medium, was found to be experiments dexamethasone was added only on d 1. For the essentially free from contaminating hemopoietic cells. Based on remaining part of the experimental 5-d period, the medium was Tryphan blue exclusion, the fetal hepatocyte preparation was replaced each day by fresh medium containing no hormone. The also shown to contain greater than 95% viable hepatocytes. The effect of warfarin was also investigated by adding the drug (50 effect of dexamethasone on vitamin K-dependent carboxylation PM) to the cells on d 1 followed by harvesting on d 2, 3, 4, and in these cells in culture is shown in Figure 1 . On d 1 (see 5. Fresh medium added on d 2, 3, and 4 did not contain any Experimental Section), the fetal cell cultures were treated with warfarin. Cells were removed from the dishes with a cell scraper. either 0.1 pM dexamethasone (open bars), 1 pM dexametha~one Microsomes and cytosol were prepared as described below.
(diagonal bars), or saline (solid bars), and this hormonal treatIsolation ofMicrosomes. Microsomesfrom livers. Livers were ment was continued for 4 more d in culture (d 2-5). Fresh homogenized in 250 mM sucrose-25 mM imidazole (pH 7.2) medium with hormones was added to the cells on each day. On containing 5 mM benzamidine and 1 mM diisoprop~l fluoro-each day, cells were harvested and vitamin K-dependent carboxphosphate (buffer A) as described (7). The homogenate was ylase activity was determined in microsomal membranes isolated centrifuged twice at 10 (I00 x g for 10 min and then at 100 (I00 from the cells. As seen in Figure 1 , dexamethasone stimulated x g for 60 min to obtain a microsomal pellet.
vitamin K-dependent carboxylase activity in cultured fetal heMicrosomes from fetal cells. Cells removed from the tissue patocytes. After 1 d in culture (Fig. 1, d 2), enhanced activity culture dishes were suspended in buffer A, washed three times which was significantly above the control ( p = 0.016), was by centrifugation, and resuspended in this buffer. For preparation measured. However, a dramatic rise in this activity was seen after of microsomes, 30 x lo6 to 50 x lo6 cells were used. The final 4 d in culture (Fig. 1, d 5 ). This pattern of dexamethasone washed cell pellet was resuspended in 2 mL of buffer A and sonicated on ice for three 10-s intervals at 50% duty cycle by mM imidazole-0.5% CHAPS-5 mM benzamidine-1 mM diisopropyl fluorophosphate (pH 7.2) (buffer B) and subjected to centrifugation at 100 000 x g for 60 min. The pellet that harbored o the membrane fragments was resuspended in buffer B for deter- Prothrombin Precursor. The microsomal concentration of the 3,4, and 5 for determination of vitamin K-dependent carboxylase activity prothrombin precursor was measured by immunodot blotting as as described in Materials and Methods. The pentapeptide FLEEL was described (12). Purified rat prothrombin was used to establish used as substrate. The data present the average activity measured in four the standard curve for the precursor concentration.
independent experiments + SEM ( n = 4). stimulation of carboxylase activity in fetal hepatocytes was very reproducible, and the data shown in Figure 4 represent the mean of four independent experiments. An additional experiment was also camed out where 1 pM dexamethasone was added to the cell culture on d 1, whereafter the medium was replaced every day by fresh medium containing no hormone. It was found that stimulation of carboxylase activity by dexamethasone, when added to the medium according to this protocol, was insignificantly different from the profile shown in Figure 1 where dexamethasone was added to the medium every day. There was also no difference in dexamethasone stimulation of carboxylase activity whether charcoal-treated FCS or untreated FCS was used in the culture medium. As control for the dexamethasone effect on cultured fetal hepatocytes, TAT activity in cytosol from the cultured cells was determined. As shown in Figure 2 , this activity was stimulated more than 10-fold in dexamethasone-treated cells and maximum stimulation was achieved after 2 d in culture (Fig.  2, d 3) . As seen in Figure 1 (solid bars), there was no significant change in carboxylase activity in the control culture over the 5-d experimental period. Because there is clearly an ongoing maturation process of the vitamin K-dependent carboxylation system in d-18 fetal livers, the unchanged carboxylase activities that were measured in the control fetal cells on d 2-5 indicate that these cells did not differentiate into adult hepatocytes under the conditions used for fetal hepatocyte cell culture. Additional data to support this conclusion were the findings of extremely low DT-diaphorase activities in cytosol from these cells, which is a documented characteristic of the fetal liver (7). Insulin in contrast to dexamethasone was shown in several similar experiments to have no effect on carboxylase activity in fetal hepatocytes cultured in the arginine-free medium (data not shown). Insulin was used in the concentration range 10-100 nM. The endogenous concentration of insulin in our culture medium was estimated to be <0.0 1 nM. Of the cytokines, we investigated the effect of IL-1, epidermal growth factor, and platelet-derived growth factor on carboxylase activity. The growth factors did not affect carboxylase activity but a small down-regulation of the activity was observed with interleukin-1 (data not shown).
Gallaher et al. (15) reported that T3, when given to pregnant rats, stimulates the activity of the fetal lung vitamin K-dependent carboxylation system. However, we found no effect on the vitamin K-dependent carboxylase when our fetal hepatocytes were cultured with T3. Also, T3 had no effect on the liver vitamin Kdepe :ndent carboxylatibn system when the hormone was admin- DAYS istered to pregnant rats by the protocol described by Gallaher et al. (15) . Carboxylase activity in livers from 20-d rat fetuses obtained from mothers treated with saline (control) and T3 (7 mg/l kg) was measured to be 22 000 + 1 300 and 21 600 k 1 500 cpm/mg, respectively. The quality of the fetal cell culture as a model system for the fetal liver was verified further by experiments where the anticoagulant warfarin was added to the medium. As shown in Figure  3 , warfarin (50 pM) enhanced carboxylase activity about twofold when the cells were treated for 24 h with the drug (Fig. 3, d 2) . This is consistent with what is known about the effect of the drug on the intact liver (14). The long-lasting effect of warfarin is also demonstrated in Figure 3 : enhanced carboxylase activity was maintained in the cells for 3 additional d (d 3-5) after the drug was removed from the cells.
Neonatal rat. The next set of experiments was designed to test dexamethasone as a potential drug for boosting carboxylase activity in the developing liver. Included in these experiments were newborn rats treated with insulin for comparison with the cell culture data which showed no effect of insulin. Neonatal rats on the 1st d of birth (within 24 h after delivery) were treated with saline (control rats), insulin, and dexamethasone, respectively. Rats were killed on d 2, 3, 5, and 7 after birth for preparation of liver microsomes and determination of carboxylase activity. The activity profiles are shown in Figure 4 for carboxylase activity determined with a synthetic peptide (panel A ) and for this activity determined as y-carboxylation of endogenous microsomal proteins (panel B). In the figure, solid bars represent control rats, open bars represent insulin-treated rats, and diagonal shaded bars represent dexamethasone-treated rats. The activity was also determined in d-21 (birth) fetuses from untreated mothers. In insulin-treated animals, the activity profile was not different from the profile in saline-treated animals. On the other hand, dexamethasone resulted in a small but significant ( p = 0.000 1) increase in activity 24 h after injection of the drug with a large increase in the activity measured in dexamethasonetreated animals on d 7 after birth. The profile shown in Figure 4 has been repeated in six independent experiments. It was concluded from these experiments that the dexamethasone effect on carboxylase activity in fetal hepatocytes in culture indeed is Fig. 2 . TAT activity measured in cultured fetal hepatocytes treated medium was replaced each day by fresh medium containing no drug. with dexamethasone. Hepatocytes from 18-d-old rat fetuses were cultured Cells were harvested on d 2, 3, 4, and 5 for determination of carboxylase for 5 d in the absence (solid bars) and presence (diagonal shaded bars) activity. The pentapeptide FLEEL was used as substrate. The data are of 1 pM dexamethasone. TAT activity was measured in cell cytosol as presented as the average activity measured in three independent experidescribed in Materials and Methods. ments + SEM (n = 3). (diagonally shaded bars). Rat pups killed at birth (birth) and neonatal rats sacrificed on d 2, 3, 4, 5, and 7 after birth were used for preparation of liver microsomes and determination of carboxylase activity as described in Materials and Methods. The activity profiles 'shown in panels A and B are for the activity determined with the FLEEL peptide and endogenous microsomal proteins, respectively, as carboxylase substrates. The data are presented as the average activity measured in six independent ex~eriments + SEM (n = 61. reflected in the intact animal. As seen with the cell culture in a parallel manner with carboxylase activity (10, 12). Because most of these studies have been conducted with the prothrombin precursor, the prothrombin precursor concentration was measured in microsomes from the neonatal rats treated with saline, insulin, and dexamethasone. As shown in Figure 5 , there was no difference in prothrombin precursor concentration in microsomes from saline (solid bars), insulin-treated (open bars), or dexamethasone-treated (diagonal bars) neonatal rats.
An additional observation was made which may aid in determining the mechanism of action of dexamethasone on carboxylase activity. This observation is interesting in light of the previous finding that microsomal membranes from warfarintreated rats show enhanced ['4C]y-carboxylation of the endogenous factor X precursor pool but not the endogenous prothrombin precursor pool (12). We carried out similar vitamin Kdependent labeling experiments with microsomal membranes isolated from the 7-d-old neonatal rats treated with saline, insulin, and dexamethasone. As shown in Figure 6 (panel A, lane 3) , dexamethasone also results in enhanced labeling of the membrane-bound factor X precursor pool which is demonstrated on the fluorogram in Figure 6 by the 70-kD band. The identity of the factor X precursor was established with factor X antibodies. Lanes 1 and 2 ( Fig. 6A ) have proteins from neonatal rats treated with insulin and saline, respectively. As shown, insulin had no effect on labeling of the 70-kD factor X precursor pool. Labeling of the membrane-bound prothrombin precursor pool, as shown by labeling of the 78-kD prothrombin precursor in Figure 6 (12), was not affected by the hormones. This effect of dexamethasone could also be demonstrated in fetal hepatocytes treated in culture for 5 d with dexamethasone. As shown in Figure 6B , labeled microsomes from dexamethasone-treated cells clearly demonstrated enhanced labeling of the factor X precursor pool (lane 1). Lane 2 (Fig. 6B ) has labeled proteins from untreated cells. The 36-kD protein has not yet been identified.
DISCUSSION
This report demonstrates that dexamethasone affects the vitamin K-dependent carboxylation system in cultured fetal hepatocytes and neonatal rat liver by producing a higher y-carboxylation activity. Stimulation of this activity by the drug was clearly delayed when compared with its stimulation of TAT activity, the enzyme activity traditionally used to monitor enzyme induc- 
DAYS
experiments, a delayed large response to dexamethasone was also Increased carboxylase activity is also associated with vitamin thrombin precursor concentration was determined in microsomes ob-K deficiency and after anticoagulation with warfarin (10). In tained from the experiment described in the legend to Figure 4 . The these cases, it has been found that the intracellular concentration precursor concentration was estimated by immunodot blotting with of the vitamin K-dependent clotting factor precursors increases purified rat prothrombin as standard (see Materials and Methods).
A B
system in the developing lung was an important finding for prevention of respiratory distress in premature infants. 1 2 3 1 2 We also show in this work that dexamethasone results in enhanced I4C labeling of the intracellular factor X precursor pool in the microsomal membrane, a finding which recently also has ' 7 8
been made with warfarin-treated rats (12). This was an unex-770 pected finding because the two drugs are known to have quite different effects in vivo. Warfarin in contrast to dexamethasone is an anticoagulant that inhibits the vitamin K cycle in liver (10). The mechanisms by which dexamethasone and warfarin both "turn on" ['4C]y-carboxylation of the membrane-associated factor X precursor pool in rat liver have not yet been elucidated.
It is a well-established observation that warfarin also results in enhanced y-carboxylation activity in liver and other tissues.
-a~ Enhanced y-carboxylase activity in rat liver induced by warfarin 3-*36 is always found associated with an increase in the intracellular prothrombin precursor concentration which, on the other hand, Fig. 6 . Vitamin K-dependent 14C labeling o f carboxylase substrates was not found when rats were treated with dexamethasone. This attached to the microsomal membrane. Liver microsomal membranes finding, together with recent data from our laboratory showing were prepared from 7-d-old neonatal rats that had been injected with that the dexamethasone effect on carboxylase activity is mediated insulin, saline, a n d dexamethasone by the protocol described in the by the glucocorticoid receptor (unpublished data), certainly suglegend to Figure 4 . These membranes were subjected to vitamin K-gest that the two drugs induce carboxylase activity by different dependent ['4Clr-carbox~lation, SDS-PAGE, and fluorography as de-mechanisms. Dexamethasone may indeed regulate y-carboxylase scribed i n Materials and Methods. T h e SDS-PAGE fluorograms of activity at the transcriptional level.
membranes from saline, insulin-, a n d dexamethasone-treated animals are shown in an el A (lanes 1, 2, and 3, respectively). Vitamin K
